Legal & General Group’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,745
| Closed | -$6K | – | 3726 |
|
|
2021
Q1 | $6K | Sell |
1,745
-174
| -9% | -$598 | ﹤0.01% | 3473 |
|
|
2020
Q4 | $6K | Hold |
1,919
| – | – | ﹤0.01% | 3425 |
|
|
2020
Q3 | $7K | Sell |
1,919
-850
| -31% | -$3.1K | ﹤0.01% | 3352 |
|
|
2020
Q2 | $13K | Buy |
2,769
+739
| +36% | +$3.47K | ﹤0.01% | 3249 |
|
|
2020
Q1 | $7K | Sell |
2,030
-865
| -30% | -$2.98K | ﹤0.01% | 3228 |
|
|
2019
Q4 | $18K | Buy |
2,895
+612
| +27% | +$3.81K | ﹤0.01% | 3216 |
|
|
2019
Q3 | $10K | Hold |
2,283
| – | – | ﹤0.01% | 3272 |
|
|
2019
Q2 | $30K | Buy |
+2,283
| New | +$30K | ﹤0.01% | 3027 |
|